FDA approves lower-cost alternative to biotech drug Humira – Uniontown Herald Standard

FDA approves lower-cost alternative to biotech drug Humira
Uniontown Herald Standard
WASHINGTON (AP) — Federal regulators on Friday approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to treat rheumatoid arthritis and other inflammatory diseases. The Food and Drug

and more »

Read Original Article: FDA approves lower-cost alternative to biotech drug Humira – Uniontown Herald Standard »

Powered by WPeMatico